Newstral
Article
Star Tribune on 2022-06-09 00:08
FDA imposes "Class I" recall status on Medtronic's latest HeartWare defect
Related news
- Another FDA recall for Medtronic's HeartWare deviceStar Tribune
- FDA issues Class I recall for software glitch in Medtronic's surgery StealthStationStar Tribune
- FDA issues warning to Medtronic's diabetes businessStar Tribune
- FDA lifts restrictions on Medtronic's diabetes businessStar Tribune
- Despite FDA warning from past recalls, agency OKs Medtronic's new insulin pumpStar Tribune
- FDA clears Medtronic's MRI-safe defibrillatorbizjournals.com
- Medtronic's artery-clearing balloon wins FDA approvalbizjournals.com
- Medtronic's tiny leadless pacemaker gets FDA approvalbizjournals.com
- Another problem appears for Medtronic's HeartWare deviceStar Tribune
- FDA issues highest-level recall for missing Medtronic video scopesStar Tribune
- Medtronic's Drug Coated Balloon Enters U.S. With FDA ApprovalForbes
- Abbott failed to reveal pacemaker defect: FDANew York Post
- FDA issues recall for 348,616 Medtronic defibrillators over potential cardiac arrest riskStar Tribune
- FDA: Medtronic slow to update, recall defective insulin pumps for diabetes patientsStar Tribune
- FDA announces ranch dressing recall19 Action News
- HFDA issues Dog Food Recallhuntingtonnews.net
- SFDA announces infant formula recallstmarynow.com
- FDA Clears Medtronic's VenaSealwsj.com
- FDA slaps Class 1 recall label on Minnesota-made syringe infusion pumpStar Tribune
- FDA warns consumers of EpiPen recallWEWS/newsnet5.com